Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Total 13F shares
-
68,109,208
-
Share change
-
-1,482,986
-
Total reported value
-
$25,959,372,992
-
Put/Call ratio
-
43%
-
Price per share
-
$382.47
-
Number of holders
-
727
-
Value change
-
-$536,833,981
-
Number of buys
-
330
-
Number of sells
-
321
Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2023
As of 30 Jun 2023,
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) was held by
727 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,109,208 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Bank of New York Mellon Corp, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, APG Asset Management N.V., FRANKLIN RESOURCES INC, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, and Durable Capital Partners LP.
This page lists
727
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.